Envision Declares Quarterly Preferred Stock Dividend




Public Company Information:



NASHVILLE, Tenn. & GREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)--Envision Healthcare Corporation (“Envision”) (NYSE: EVHC) today announced that its Board of Directors has declared a quarterly dividend of $1.3125 per share in cash for the Company’s 5.250% Mandatory Convertible Preferred Stock, Series A-1 (the “Preferred Stock”). The dividend is payable on July 3, 2017, which is the first business day following the dividend payment date of July 1, 2017, to preferred stockholders of record as of June 15, 2017.

Unless converted earlier, each share of Preferred Stock will convert automatically on July 3, 2017, which is the first business day following the conversion date of July 1, 2017, into between 1.8141 and 2.2222 shares of Envision common stock. The number of shares of common stock issuable upon conversion will be determined based on the volume weighted average price per share of Envision common stock over the 20 consecutive trading day period commencing on and including the 22nd scheduled trading day immediately preceding the mandatory conversion date.

About Envision Healthcare Corporation

Envision Healthcare Corporation is a leading provider of physician-led services and post-acute care, and ambulatory surgery services. At March 31, 2017, we delivered physician services, primarily in the areas of emergency department and hospitalist services, anesthesiology services, radiology/tele-radiology services, and children’s services to more than 1,600 clinical departments in healthcare facilities in 45 states and the District of Columbia. Post-acute care is delivered through an array of clinical professionals and integrated technologies which, when combined, contribute to efficient and effective population health management strategies. As a market leader in ambulatory surgical care, the Company owns and operates 264 surgery centers and one surgical hospital in 35 states and the District of Columbia, with medical specialties ranging from gastroenterology to ophthalmology and orthopaedics. In total, the Company offers a differentiated suite of clinical solutions on a national scale, creating value for health systems, payors, providers and patients. For additional information, visit www.evhc.net.


Envision Healthcare Corporation
Bob Kneeley, 303-495-1245
Vice President, Investor Relations